MicroRNAs Play a Role in Parkinson's Disease by Regulating Microglia Function: From Pathogenetic Involvement to

Silu Li1, Guorong Bi2, Shunchang Han2

  • 1Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, China.

Insights

Microglia overactivation drives Parkinson's disease (PD) progression. MicroRNAs (miRNAs) offer a novel therapeutic strategy by regulating microglia function and polarization in PD.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Parkinson's disease (PD) involves dopamine neuron loss in the substantia nigra.
  • Microglia (MG), the central nervous system's immune cells, are implicated in PD pathogenesis through overactivation and inflammation.
  • MicroRNAs (miRNAs) are key gene regulators involved in immune and inflammatory processes.

Purpose of the Study:

  • To review the role of microglial pathological polarization in PD progression.
  • To elucidate the mechanisms by which miRNAs regulate microglia in PD.
  • To explore miRNA-based therapeutic strategies for PD.

Main Methods:

  • Literature review of recent articles on PD, microglia, and miRNAs.
  • Analysis of miRNA regulation of microglia gene expression and polarization.
  • Synthesis of current understanding of miRNA functions in PD pathogenesis.

Main Results:

  • Microglial overactivation is a critical factor in PD.
  • miRNAs significantly influence MG polarization and function.
  • Dysregulated miRNA activity contributes to PD progression.

Conclusions:

  • Microglial pathological polarization is central to PD.
  • miRNAs represent a promising therapeutic target for PD.
  • Regulating miRNAs may offer a novel protective approach against PD.